nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—CHRNA2—epilepsy syndrome	0.323	0.442	CbGaD
Carbachol—CHRM3—epilepsy syndrome	0.152	0.207	CbGaD
Carbachol—CHRM1—epilepsy syndrome	0.141	0.193	CbGaD
Carbachol—CHRM2—epilepsy syndrome	0.115	0.158	CbGaD
Carbachol—Bethanechol—CHRM3—epilepsy syndrome	0.00122	0.23	CrCbGaD
Carbachol—CHRNA2—forebrain—epilepsy syndrome	0.00115	0.0778	CbGeAlD
Carbachol—Bethanechol—CHRM2—epilepsy syndrome	0.000926	0.175	CrCbGaD
Carbachol—Succinylcholine—CHRM3—epilepsy syndrome	0.000843	0.159	CrCbGaD
Carbachol—Succinylcholine—CHRM1—epilepsy syndrome	0.000786	0.149	CrCbGaD
Carbachol—CHRM2—forebrain—epilepsy syndrome	0.000686	0.0464	CbGeAlD
Carbachol—PLA2G4A—medulla oblongata—epilepsy syndrome	0.000672	0.0455	CbGeAlD
Carbachol—CHRNA2—head—epilepsy syndrome	0.000659	0.0445	CbGeAlD
Carbachol—Succinylcholine—CHRM2—epilepsy syndrome	0.000642	0.121	CrCbGaD
Carbachol—CHRM2—telencephalon—epilepsy syndrome	0.000631	0.0427	CbGeAlD
Carbachol—CHRM1—forebrain—epilepsy syndrome	0.000624	0.0422	CbGeAlD
Carbachol—CHRNA2—nervous system—epilepsy syndrome	0.000624	0.0422	CbGeAlD
Carbachol—PLA2G4A—midbrain—epilepsy syndrome	0.000615	0.0416	CbGeAlD
Carbachol—CHRNA2—central nervous system—epilepsy syndrome	0.000601	0.0406	CbGeAlD
Carbachol—PLA2G4A—spinal cord—epilepsy syndrome	0.0006	0.0405	CbGeAlD
Carbachol—CHRNA2—cerebellum—epilepsy syndrome	0.000587	0.0397	CbGeAlD
Carbachol—CHRM1—telencephalon—epilepsy syndrome	0.000574	0.0388	CbGeAlD
Carbachol—CHRM3—forebrain—epilepsy syndrome	0.000559	0.0378	CbGeAlD
Carbachol—Succinylcholine—BCHE—epilepsy syndrome	0.000535	0.101	CrCbGaD
Carbachol—CHRM3—telencephalon—epilepsy syndrome	0.000514	0.0347	CbGeAlD
Carbachol—PLA2G4A—nervous system—epilepsy syndrome	0.000505	0.0342	CbGeAlD
Carbachol—PLA2G4A—central nervous system—epilepsy syndrome	0.000486	0.0329	CbGeAlD
Carbachol—CHRNA2—brain—epilepsy syndrome	0.000477	0.0323	CbGeAlD
Carbachol—CHRM2—head—epilepsy syndrome	0.000393	0.0266	CbGeAlD
Carbachol—PLA2G4A—brain—epilepsy syndrome	0.000386	0.0261	CbGeAlD
Carbachol—CHRM2—nervous system—epilepsy syndrome	0.000372	0.0252	CbGeAlD
Carbachol—CHRM2—central nervous system—epilepsy syndrome	0.000358	0.0242	CbGeAlD
Carbachol—CHRM1—head—epilepsy syndrome	0.000357	0.0242	CbGeAlD
Carbachol—Choline—BCHE—epilepsy syndrome	0.00034	0.0644	CrCbGaD
Carbachol—CHRM1—nervous system—epilepsy syndrome	0.000339	0.0229	CbGeAlD
Carbachol—CHRM1—central nervous system—epilepsy syndrome	0.000326	0.0221	CbGeAlD
Carbachol—CHRM3—head—epilepsy syndrome	0.00032	0.0216	CbGeAlD
Carbachol—CHRM3—nervous system—epilepsy syndrome	0.000303	0.0205	CbGeAlD
Carbachol—CHRM3—central nervous system—epilepsy syndrome	0.000292	0.0197	CbGeAlD
Carbachol—CHRM2—brain—epilepsy syndrome	0.000285	0.0192	CbGeAlD
Carbachol—CHRM1—brain—epilepsy syndrome	0.000259	0.0175	CbGeAlD
Carbachol—CHRM3—brain—epilepsy syndrome	0.000232	0.0157	CbGeAlD
Carbachol—Dizziness—Lacosamide—epilepsy syndrome	0.000228	0.00165	CcSEcCtD
Carbachol—Syncope—Lamotrigine—epilepsy syndrome	0.000228	0.00165	CcSEcCtD
Carbachol—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000228	0.00164	CcSEcCtD
Carbachol—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000227	0.00164	CcSEcCtD
Carbachol—Infection—Clonazepam—epilepsy syndrome	0.000225	0.00162	CcSEcCtD
Carbachol—Hypotension—Felbamate—epilepsy syndrome	0.000224	0.00162	CcSEcCtD
Carbachol—Sweating—Pregabalin—epilepsy syndrome	0.000224	0.00162	CcSEcCtD
Carbachol—Loss of consciousness—Lamotrigine—epilepsy syndrome	0.000224	0.00161	CcSEcCtD
Carbachol—Infection—Phenytoin—epilepsy syndrome	0.000224	0.00161	CcSEcCtD
Carbachol—Nausea—Phenobarbital—epilepsy syndrome	0.000222	0.00161	CcSEcCtD
Carbachol—Infection—Oxcarbazepine—epilepsy syndrome	0.000222	0.00161	CcSEcCtD
Carbachol—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000222	0.0016	CcSEcCtD
Carbachol—Dizziness—Clobazam—epilepsy syndrome	0.000221	0.0016	CcSEcCtD
Carbachol—Shock—Phenytoin—epilepsy syndrome	0.000221	0.0016	CcSEcCtD
Carbachol—Shock—Oxcarbazepine—epilepsy syndrome	0.00022	0.00159	CcSEcCtD
Carbachol—Hypotension—Zonisamide—epilepsy syndrome	0.00022	0.00159	CcSEcCtD
Carbachol—Vomiting—Lacosamide—epilepsy syndrome	0.000219	0.00158	CcSEcCtD
Carbachol—Abdominal pain—Propofol—epilepsy syndrome	0.000219	0.00158	CcSEcCtD
Carbachol—Body temperature increased—Propofol—epilepsy syndrome	0.000219	0.00158	CcSEcCtD
Carbachol—Dyspepsia—Diazepam—epilepsy syndrome	0.000218	0.00158	CcSEcCtD
Carbachol—Nausea—Rufinamide—epilepsy syndrome	0.000218	0.00158	CcSEcCtD
Carbachol—Rash—Lacosamide—epilepsy syndrome	0.000218	0.00157	CcSEcCtD
Carbachol—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000218	0.00157	CcSEcCtD
Carbachol—Dermatitis—Lacosamide—epilepsy syndrome	0.000217	0.00157	CcSEcCtD
Carbachol—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000216	0.00156	CcSEcCtD
Carbachol—Headache—Lacosamide—epilepsy syndrome	0.000216	0.00156	CcSEcCtD
Carbachol—Pain—Vigabatrin—epilepsy syndrome	0.000215	0.00156	CcSEcCtD
Carbachol—Infection—Carbamazepine—epilepsy syndrome	0.000213	0.00154	CcSEcCtD
Carbachol—Vomiting—Clobazam—epilepsy syndrome	0.000213	0.00154	CcSEcCtD
Carbachol—Pain—Diazepam—epilepsy syndrome	0.000212	0.00153	CcSEcCtD
Carbachol—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000212	0.00153	CcSEcCtD
Carbachol—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000212	0.00153	CcSEcCtD
Carbachol—Hypotension—Clonazepam—epilepsy syndrome	0.000212	0.00153	CcSEcCtD
Carbachol—Dyspepsia—Felbamate—epilepsy syndrome	0.000211	0.00153	CcSEcCtD
Carbachol—Shock—Carbamazepine—epilepsy syndrome	0.000211	0.00153	CcSEcCtD
Carbachol—Rash—Clobazam—epilepsy syndrome	0.000211	0.00152	CcSEcCtD
Carbachol—Dermatitis—Clobazam—epilepsy syndrome	0.000211	0.00152	CcSEcCtD
Carbachol—Hypotension—Phenytoin—epilepsy syndrome	0.00021	0.00152	CcSEcCtD
Carbachol—Headache—Clobazam—epilepsy syndrome	0.00021	0.00151	CcSEcCtD
Carbachol—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000209	0.00151	CcSEcCtD
Carbachol—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000208	0.0015	CcSEcCtD
Carbachol—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000207	0.0015	CcSEcCtD
Carbachol—Dyspepsia—Zonisamide—epilepsy syndrome	0.000207	0.00149	CcSEcCtD
Carbachol—Infection—Lamotrigine—epilepsy syndrome	0.000206	0.00149	CcSEcCtD
Carbachol—Sweating—Gabapentin—epilepsy syndrome	0.000206	0.00148	CcSEcCtD
Carbachol—Pain—Felbamate—epilepsy syndrome	0.000205	0.00148	CcSEcCtD
Carbachol—Nausea—Lacosamide—epilepsy syndrome	0.000205	0.00148	CcSEcCtD
Carbachol—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000204	0.00148	CcSEcCtD
Carbachol—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000204	0.00147	CcSEcCtD
Carbachol—Shock—Lamotrigine—epilepsy syndrome	0.000204	0.00147	CcSEcCtD
Carbachol—Asthma—Topiramate—epilepsy syndrome	0.000202	0.00146	CcSEcCtD
Carbachol—Hypotension—Carbamazepine—epilepsy syndrome	0.000201	0.00145	CcSEcCtD
Carbachol—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000201	0.00145	CcSEcCtD
Carbachol—Dyspepsia—Clonazepam—epilepsy syndrome	0.000199	0.00144	CcSEcCtD
Carbachol—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000199	0.00144	CcSEcCtD
Carbachol—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000199	0.00144	CcSEcCtD
Carbachol—Flatulence—Valproic Acid—epilepsy syndrome	0.000199	0.00144	CcSEcCtD
Carbachol—Nausea—Clobazam—epilepsy syndrome	0.000199	0.00144	CcSEcCtD
Carbachol—Dyspepsia—Phenytoin—epilepsy syndrome	0.000198	0.00143	CcSEcCtD
Carbachol—Dizziness—Acetazolamide—epilepsy syndrome	0.000197	0.00143	CcSEcCtD
Carbachol—Sweating increased—Topiramate—epilepsy syndrome	0.000197	0.00142	CcSEcCtD
Carbachol—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000197	0.00142	CcSEcCtD
Carbachol—Abdominal pain—Diazepam—epilepsy syndrome	0.000196	0.00142	CcSEcCtD
Carbachol—Flushing—Pregabalin—epilepsy syndrome	0.000195	0.00141	CcSEcCtD
Carbachol—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000194	0.0014	CcSEcCtD
Carbachol—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000194	0.0014	CcSEcCtD
Carbachol—Pain—Clonazepam—epilepsy syndrome	0.000194	0.0014	CcSEcCtD
Carbachol—Pain—Oxcarbazepine—epilepsy syndrome	0.000191	0.00138	CcSEcCtD
Carbachol—Body temperature increased—Felbamate—epilepsy syndrome	0.00019	0.00137	CcSEcCtD
Carbachol—Abdominal pain—Felbamate—epilepsy syndrome	0.00019	0.00137	CcSEcCtD
Carbachol—Vomiting—Acetazolamide—epilepsy syndrome	0.00019	0.00137	CcSEcCtD
Carbachol—Diarrhoea—Propofol—epilepsy syndrome	0.00019	0.00137	CcSEcCtD
Carbachol—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000189	0.00137	CcSEcCtD
Carbachol—Arrhythmia—Pregabalin—epilepsy syndrome	0.000188	0.00135	CcSEcCtD
Carbachol—Headache—Acetazolamide—epilepsy syndrome	0.000187	0.00135	CcSEcCtD
Carbachol—Abdominal pain—Zonisamide—epilepsy syndrome	0.000186	0.00134	CcSEcCtD
Carbachol—Body temperature increased—Zonisamide—epilepsy syndrome	0.000186	0.00134	CcSEcCtD
Carbachol—Pain—Carbamazepine—epilepsy syndrome	0.000184	0.00133	CcSEcCtD
Carbachol—Dizziness—Propofol—epilepsy syndrome	0.000183	0.00132	CcSEcCtD
Carbachol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000183	0.00132	CcSEcCtD
Carbachol—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000183	0.00132	CcSEcCtD
Carbachol—Flatulence—Pregabalin—epilepsy syndrome	0.00018	0.0013	CcSEcCtD
Carbachol—Dizziness—Midazolam—epilepsy syndrome	0.000179	0.0013	CcSEcCtD
Carbachol—Body temperature increased—Clonazepam—epilepsy syndrome	0.000179	0.00129	CcSEcCtD
Carbachol—Abdominal pain—Clonazepam—epilepsy syndrome	0.000179	0.00129	CcSEcCtD
Carbachol—Body temperature increased—Phenytoin—epilepsy syndrome	0.000178	0.00128	CcSEcCtD
Carbachol—Pain—Lamotrigine—epilepsy syndrome	0.000178	0.00128	CcSEcCtD
Carbachol—Nausea—Acetazolamide—epilepsy syndrome	0.000177	0.00128	CcSEcCtD
Carbachol—Dizziness—Levetiracetam—epilepsy syndrome	0.000177	0.00128	CcSEcCtD
Carbachol—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000177	0.00128	CcSEcCtD
Carbachol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000177	0.00128	CcSEcCtD
Carbachol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000177	0.00128	CcSEcCtD
Carbachol—Vomiting—Propofol—epilepsy syndrome	0.000176	0.00127	CcSEcCtD
Carbachol—Muscle spasms—Pregabalin—epilepsy syndrome	0.000176	0.00127	CcSEcCtD
Carbachol—Rash—Propofol—epilepsy syndrome	0.000175	0.00126	CcSEcCtD
Carbachol—Dermatitis—Propofol—epilepsy syndrome	0.000175	0.00126	CcSEcCtD
Carbachol—Headache—Propofol—epilepsy syndrome	0.000174	0.00125	CcSEcCtD
Carbachol—Vomiting—Midazolam—epilepsy syndrome	0.000172	0.00125	CcSEcCtD
Carbachol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000172	0.00124	CcSEcCtD
Carbachol—Rash—Midazolam—epilepsy syndrome	0.000171	0.00123	CcSEcCtD
Carbachol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000171	0.00123	CcSEcCtD
Carbachol—Dermatitis—Midazolam—epilepsy syndrome	0.000171	0.00123	CcSEcCtD
Carbachol—Vomiting—Levetiracetam—epilepsy syndrome	0.00017	0.00123	CcSEcCtD
Carbachol—Headache—Midazolam—epilepsy syndrome	0.00017	0.00123	CcSEcCtD
Carbachol—Abdominal pain—Carbamazepine—epilepsy syndrome	0.00017	0.00123	CcSEcCtD
Carbachol—Body temperature increased—Carbamazepine—epilepsy syndrome	0.00017	0.00123	CcSEcCtD
Carbachol—Diarrhoea—Diazepam—epilepsy syndrome	0.00017	0.00123	CcSEcCtD
Carbachol—Rash—Levetiracetam—epilepsy syndrome	0.000169	0.00122	CcSEcCtD
Carbachol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000169	0.00122	CcSEcCtD
Carbachol—Headache—Levetiracetam—epilepsy syndrome	0.000168	0.00121	CcSEcCtD
Carbachol—Dizziness—Vigabatrin—epilepsy syndrome	0.000167	0.0012	CcSEcCtD
Carbachol—Flatulence—Gabapentin—epilepsy syndrome	0.000165	0.00119	CcSEcCtD
Carbachol—Nausea—Propofol—epilepsy syndrome	0.000165	0.00119	CcSEcCtD
Carbachol—Vomiting—Fosphenytoin—epilepsy syndrome	0.000164	0.00119	CcSEcCtD
Carbachol—Diarrhoea—Felbamate—epilepsy syndrome	0.000164	0.00119	CcSEcCtD
Carbachol—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000164	0.00118	CcSEcCtD
Carbachol—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000164	0.00118	CcSEcCtD
Carbachol—Dizziness—Diazepam—epilepsy syndrome	0.000164	0.00118	CcSEcCtD
Carbachol—Infection—Valproic Acid—epilepsy syndrome	0.000164	0.00118	CcSEcCtD
Carbachol—Syncope—Pregabalin—epilepsy syndrome	0.000164	0.00118	CcSEcCtD
Carbachol—Rash—Fosphenytoin—epilepsy syndrome	0.000163	0.00118	CcSEcCtD
Carbachol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000163	0.00118	CcSEcCtD
Carbachol—Headache—Fosphenytoin—epilepsy syndrome	0.000162	0.00117	CcSEcCtD
Carbachol—Nausea—Midazolam—epilepsy syndrome	0.000161	0.00116	CcSEcCtD
Carbachol—Muscle spasms—Gabapentin—epilepsy syndrome	0.000161	0.00116	CcSEcCtD
Carbachol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000161	0.00116	CcSEcCtD
Carbachol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000161	0.00116	CcSEcCtD
Carbachol—Vomiting—Vigabatrin—epilepsy syndrome	0.00016	0.00116	CcSEcCtD
Carbachol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000159	0.00115	CcSEcCtD
Carbachol—Nausea—Levetiracetam—epilepsy syndrome	0.000159	0.00115	CcSEcCtD
Carbachol—Rash—Vigabatrin—epilepsy syndrome	0.000159	0.00115	CcSEcCtD
Carbachol—Dizziness—Felbamate—epilepsy syndrome	0.000159	0.00115	CcSEcCtD
Carbachol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000159	0.00115	CcSEcCtD
Carbachol—Headache—Vigabatrin—epilepsy syndrome	0.000158	0.00114	CcSEcCtD
Carbachol—Vomiting—Diazepam—epilepsy syndrome	0.000158	0.00114	CcSEcCtD
Carbachol—Rash—Diazepam—epilepsy syndrome	0.000156	0.00113	CcSEcCtD
Carbachol—Dermatitis—Diazepam—epilepsy syndrome	0.000156	0.00113	CcSEcCtD
Carbachol—Dizziness—Zonisamide—epilepsy syndrome	0.000155	0.00112	CcSEcCtD
Carbachol—Headache—Diazepam—epilepsy syndrome	0.000155	0.00112	CcSEcCtD
Carbachol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000155	0.00112	CcSEcCtD
Carbachol—Hypotension—Valproic Acid—epilepsy syndrome	0.000154	0.00111	CcSEcCtD
Carbachol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000154	0.00111	CcSEcCtD
Carbachol—Nausea—Fosphenytoin—epilepsy syndrome	0.000154	0.00111	CcSEcCtD
Carbachol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000153	0.00111	CcSEcCtD
Carbachol—Vomiting—Felbamate—epilepsy syndrome	0.000153	0.0011	CcSEcCtD
Carbachol—Rash—Felbamate—epilepsy syndrome	0.000151	0.00109	CcSEcCtD
Carbachol—Dermatitis—Felbamate—epilepsy syndrome	0.000151	0.00109	CcSEcCtD
Carbachol—Headache—Felbamate—epilepsy syndrome	0.00015	0.00109	CcSEcCtD
Carbachol—Flushing—Topiramate—epilepsy syndrome	0.00015	0.00109	CcSEcCtD
Carbachol—Syncope—Gabapentin—epilepsy syndrome	0.00015	0.00108	CcSEcCtD
Carbachol—Dizziness—Clonazepam—epilepsy syndrome	0.00015	0.00108	CcSEcCtD
Carbachol—Nausea—Vigabatrin—epilepsy syndrome	0.00015	0.00108	CcSEcCtD
Carbachol—Vomiting—Zonisamide—epilepsy syndrome	0.000149	0.00108	CcSEcCtD
Carbachol—Dizziness—Phenytoin—epilepsy syndrome	0.000149	0.00107	CcSEcCtD
Carbachol—Rash—Zonisamide—epilepsy syndrome	0.000148	0.00107	CcSEcCtD
Carbachol—Infection—Pregabalin—epilepsy syndrome	0.000148	0.00107	CcSEcCtD
Carbachol—Dermatitis—Zonisamide—epilepsy syndrome	0.000148	0.00107	CcSEcCtD
Carbachol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000148	0.00107	CcSEcCtD
Carbachol—Nausea—Diazepam—epilepsy syndrome	0.000147	0.00106	CcSEcCtD
Carbachol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000147	0.00106	CcSEcCtD
Carbachol—Headache—Zonisamide—epilepsy syndrome	0.000147	0.00106	CcSEcCtD
Carbachol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000147	0.00106	CcSEcCtD
Carbachol—Shock—Pregabalin—epilepsy syndrome	0.000147	0.00106	CcSEcCtD
Carbachol—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000145	0.00105	CcSEcCtD
Carbachol—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000144	0.00104	CcSEcCtD
Carbachol—Vomiting—Clonazepam—epilepsy syndrome	0.000144	0.00104	CcSEcCtD
Carbachol—Vomiting—Phenytoin—epilepsy syndrome	0.000143	0.00103	CcSEcCtD
Carbachol—Rash—Clonazepam—epilepsy syndrome	0.000143	0.00103	CcSEcCtD
Carbachol—Dermatitis—Clonazepam—epilepsy syndrome	0.000143	0.00103	CcSEcCtD
Carbachol—Nausea—Felbamate—epilepsy syndrome	0.000143	0.00103	CcSEcCtD
Carbachol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000142	0.00103	CcSEcCtD
Carbachol—Dizziness—Carbamazepine—epilepsy syndrome	0.000142	0.00103	CcSEcCtD
Carbachol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000142	0.00103	CcSEcCtD
Carbachol—Headache—Clonazepam—epilepsy syndrome	0.000142	0.00102	CcSEcCtD
Carbachol—Rash—Phenytoin—epilepsy syndrome	0.000142	0.00102	CcSEcCtD
Carbachol—Dermatitis—Phenytoin—epilepsy syndrome	0.000142	0.00102	CcSEcCtD
Carbachol—Rash—Oxcarbazepine—epilepsy syndrome	0.000141	0.00102	CcSEcCtD
Carbachol—Pain—Valproic Acid—epilepsy syndrome	0.000141	0.00102	CcSEcCtD
Carbachol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000141	0.00102	CcSEcCtD
Carbachol—Headache—Phenytoin—epilepsy syndrome	0.000141	0.00102	CcSEcCtD
Carbachol—Headache—Oxcarbazepine—epilepsy syndrome	0.00014	0.00101	CcSEcCtD
Carbachol—Nausea—Zonisamide—epilepsy syndrome	0.00014	0.00101	CcSEcCtD
Carbachol—Hypotension—Pregabalin—epilepsy syndrome	0.000139	0.00101	CcSEcCtD
Carbachol—Flatulence—Topiramate—epilepsy syndrome	0.000139	0.001	CcSEcCtD
Carbachol—Dizziness—Lamotrigine—epilepsy syndrome	0.000137	0.000991	CcSEcCtD
Carbachol—Vomiting—Carbamazepine—epilepsy syndrome	0.000137	0.000986	CcSEcCtD
Carbachol—Infection—Gabapentin—epilepsy syndrome	0.000136	0.000981	CcSEcCtD
Carbachol—Muscle spasms—Topiramate—epilepsy syndrome	0.000136	0.000979	CcSEcCtD
Carbachol—Rash—Carbamazepine—epilepsy syndrome	0.000135	0.000978	CcSEcCtD
Carbachol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000135	0.000977	CcSEcCtD
Carbachol—Nausea—Clonazepam—epilepsy syndrome	0.000135	0.000972	CcSEcCtD
Carbachol—Headache—Carbamazepine—epilepsy syndrome	0.000135	0.000972	CcSEcCtD
Carbachol—Shock—Gabapentin—epilepsy syndrome	0.000135	0.000971	CcSEcCtD
Carbachol—Nausea—Phenytoin—epilepsy syndrome	0.000134	0.000965	CcSEcCtD
Carbachol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000133	0.00096	CcSEcCtD
Carbachol—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000132	0.000954	CcSEcCtD
Carbachol—Vomiting—Lamotrigine—epilepsy syndrome	0.000132	0.000953	CcSEcCtD
Carbachol—Rash—Lamotrigine—epilepsy syndrome	0.000131	0.000945	CcSEcCtD
Carbachol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000131	0.000944	CcSEcCtD
Carbachol—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00013	0.000941	CcSEcCtD
Carbachol—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00013	0.000941	CcSEcCtD
Carbachol—Headache—Lamotrigine—epilepsy syndrome	0.00013	0.000939	CcSEcCtD
Carbachol—Hypotension—Gabapentin—epilepsy syndrome	0.000128	0.000923	CcSEcCtD
Carbachol—Nausea—Carbamazepine—epilepsy syndrome	0.000128	0.000921	CcSEcCtD
Carbachol—Pain—Pregabalin—epilepsy syndrome	0.000128	0.000921	CcSEcCtD
Carbachol—Syncope—Topiramate—epilepsy syndrome	0.000126	0.000913	CcSEcCtD
Carbachol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000124	0.000895	CcSEcCtD
Carbachol—Nausea—Lamotrigine—epilepsy syndrome	0.000123	0.00089	CcSEcCtD
Carbachol—Dyspepsia—Gabapentin—epilepsy syndrome	0.00012	0.000869	CcSEcCtD
Carbachol—Abdominal pain—Pregabalin—epilepsy syndrome	0.000118	0.000851	CcSEcCtD
Carbachol—Body temperature increased—Pregabalin—epilepsy syndrome	0.000118	0.000851	CcSEcCtD
Carbachol—Pain—Gabapentin—epilepsy syndrome	0.000117	0.000844	CcSEcCtD
Carbachol—Infection—Topiramate—epilepsy syndrome	0.000114	0.000825	CcSEcCtD
Carbachol—Shock—Topiramate—epilepsy syndrome	0.000113	0.000817	CcSEcCtD
Carbachol—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000113	0.000815	CcSEcCtD
Carbachol—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000111	0.000803	CcSEcCtD
Carbachol—Dizziness—Valproic Acid—epilepsy syndrome	0.000109	0.000788	CcSEcCtD
Carbachol—Body temperature increased—Gabapentin—epilepsy syndrome	0.000108	0.00078	CcSEcCtD
Carbachol—Abdominal pain—Gabapentin—epilepsy syndrome	0.000108	0.00078	CcSEcCtD
Carbachol—Hypotension—Topiramate—epilepsy syndrome	0.000107	0.000776	CcSEcCtD
Carbachol—Vomiting—Valproic Acid—epilepsy syndrome	0.000105	0.000757	CcSEcCtD
Carbachol—Rash—Valproic Acid—epilepsy syndrome	0.000104	0.000751	CcSEcCtD
Carbachol—Dermatitis—Valproic Acid—epilepsy syndrome	0.000104	0.00075	CcSEcCtD
Carbachol—Headache—Valproic Acid—epilepsy syndrome	0.000103	0.000746	CcSEcCtD
Carbachol—Diarrhoea—Pregabalin—epilepsy syndrome	0.000102	0.000737	CcSEcCtD
Carbachol—Dyspepsia—Topiramate—epilepsy syndrome	0.000101	0.000731	CcSEcCtD
Carbachol—Dizziness—Pregabalin—epilepsy syndrome	9.86e-05	0.000712	CcSEcCtD
Carbachol—Pain—Topiramate—epilepsy syndrome	9.84e-05	0.00071	CcSEcCtD
Carbachol—Nausea—Valproic Acid—epilepsy syndrome	9.8e-05	0.000707	CcSEcCtD
Carbachol—Vomiting—Pregabalin—epilepsy syndrome	9.48e-05	0.000685	CcSEcCtD
Carbachol—Rash—Pregabalin—epilepsy syndrome	9.4e-05	0.000679	CcSEcCtD
Carbachol—Dermatitis—Pregabalin—epilepsy syndrome	9.39e-05	0.000678	CcSEcCtD
Carbachol—Diarrhoea—Gabapentin—epilepsy syndrome	9.36e-05	0.000676	CcSEcCtD
Carbachol—Headache—Pregabalin—epilepsy syndrome	9.34e-05	0.000675	CcSEcCtD
Carbachol—Body temperature increased—Topiramate—epilepsy syndrome	9.09e-05	0.000657	CcSEcCtD
Carbachol—Abdominal pain—Topiramate—epilepsy syndrome	9.09e-05	0.000657	CcSEcCtD
Carbachol—Dizziness—Gabapentin—epilepsy syndrome	9.04e-05	0.000653	CcSEcCtD
Carbachol—Nausea—Pregabalin—epilepsy syndrome	8.86e-05	0.00064	CcSEcCtD
Carbachol—Vomiting—Gabapentin—epilepsy syndrome	8.69e-05	0.000628	CcSEcCtD
Carbachol—Rash—Gabapentin—epilepsy syndrome	8.62e-05	0.000623	CcSEcCtD
Carbachol—Dermatitis—Gabapentin—epilepsy syndrome	8.61e-05	0.000622	CcSEcCtD
Carbachol—Headache—Gabapentin—epilepsy syndrome	8.57e-05	0.000619	CcSEcCtD
Carbachol—Nausea—Gabapentin—epilepsy syndrome	8.12e-05	0.000586	CcSEcCtD
Carbachol—Diarrhoea—Topiramate—epilepsy syndrome	7.87e-05	0.000568	CcSEcCtD
Carbachol—Dizziness—Topiramate—epilepsy syndrome	7.61e-05	0.000549	CcSEcCtD
Carbachol—Vomiting—Topiramate—epilepsy syndrome	7.31e-05	0.000528	CcSEcCtD
Carbachol—Rash—Topiramate—epilepsy syndrome	7.25e-05	0.000524	CcSEcCtD
Carbachol—Dermatitis—Topiramate—epilepsy syndrome	7.25e-05	0.000523	CcSEcCtD
Carbachol—Headache—Topiramate—epilepsy syndrome	7.21e-05	0.00052	CcSEcCtD
Carbachol—Nausea—Topiramate—epilepsy syndrome	6.83e-05	0.000493	CcSEcCtD
Carbachol—PLA2G4A—Signaling Pathways—HES1—epilepsy syndrome	8.82e-06	8.01e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AGT—epilepsy syndrome	8.8e-06	8e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	8.77e-06	7.97e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	8.69e-06	7.9e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.69e-06	7.9e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	8.67e-06	7.88e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.66e-06	7.87e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—APOE—epilepsy syndrome	8.62e-06	7.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	8.62e-06	7.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—BCHE—epilepsy syndrome	8.59e-06	7.81e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	8.58e-06	7.8e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.58e-06	7.8e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FYN—epilepsy syndrome	8.57e-06	7.79e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—H2AFX—epilepsy syndrome	8.54e-06	7.76e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MEF2C—epilepsy syndrome	8.53e-06	7.75e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	8.47e-06	7.7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.47e-06	7.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	8.45e-06	7.68e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	8.45e-06	7.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	8.36e-06	7.6e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	8.36e-06	7.6e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	8.25e-06	7.49e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—YWHAZ—epilepsy syndrome	8.24e-06	7.49e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	8.22e-06	7.47e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	8.19e-06	7.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	8.17e-06	7.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	8.17e-06	7.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	8.17e-06	7.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	8.17e-06	7.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	8.17e-06	7.43e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NGF—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	8.15e-06	7.41e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	8.14e-06	7.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PLCB1—epilepsy syndrome	8.1e-06	7.37e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TH—epilepsy syndrome	8.07e-06	7.34e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	8.07e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	8.07e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	8.07e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	8.07e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	8.07e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	8.06e-06	7.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	8.04e-06	7.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	7.96e-06	7.23e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCR5—epilepsy syndrome	7.93e-06	7.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	7.89e-06	7.17e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	7.87e-06	7.15e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	7.79e-06	7.08e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HTR2A—epilepsy syndrome	7.76e-06	7.05e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.62e-06	6.92e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	7.6e-06	6.91e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	7.6e-06	6.91e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.59e-06	6.9e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	7.58e-06	6.88e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	7.58e-06	6.88e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.52e-06	6.84e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	7.5e-06	6.82e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	7.5e-06	6.82e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	7.49e-06	6.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	7.46e-06	6.78e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—POMC—epilepsy syndrome	7.41e-06	6.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SST—epilepsy syndrome	7.39e-06	6.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	7.39e-06	6.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	7.39e-06	6.72e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	7.39e-06	6.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	7.37e-06	6.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	7.37e-06	6.7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TSC2—epilepsy syndrome	7.37e-06	6.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SST—epilepsy syndrome	7.37e-06	6.7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGT—epilepsy syndrome	7.36e-06	6.69e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	7.33e-06	6.66e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—epilepsy syndrome	7.33e-06	6.66e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	7.3e-06	6.64e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	7.3e-06	6.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	7.3e-06	6.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SST—epilepsy syndrome	7.3e-06	6.63e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.23e-06	6.57e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	7.23e-06	6.57e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APOE—epilepsy syndrome	7.21e-06	6.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.21e-06	6.55e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	7.2e-06	6.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	7.18e-06	6.53e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	7.14e-06	6.49e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	7.11e-06	6.46e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KDR—epilepsy syndrome	7.06e-06	6.42e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	6.95e-06	6.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.95e-06	6.32e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	6.94e-06	6.31e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	6.93e-06	6.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	6.93e-06	6.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.92e-06	6.29e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	6.92e-06	6.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	6.9e-06	6.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.89e-06	6.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	6.87e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	6.86e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	6.86e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	6.85e-06	6.23e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	6.83e-06	6.21e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	6.82e-06	6.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	6.82e-06	6.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	6.8e-06	6.18e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PRKCB—epilepsy syndrome	6.8e-06	6.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	6.8e-06	6.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	6.8e-06	6.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	6.8e-06	6.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	6.78e-06	6.16e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6ST—epilepsy syndrome	6.77e-06	6.16e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ALB—epilepsy syndrome	6.75e-06	6.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HMOX1—epilepsy syndrome	6.74e-06	6.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	6.73e-06	6.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	6.73e-06	6.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	6.71e-06	6.1e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	6.66e-06	6.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAT—epilepsy syndrome	6.65e-06	6.04e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	6.63e-06	6.03e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	6.57e-06	5.97e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ABCB1—epilepsy syndrome	6.47e-06	5.88e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	6.46e-06	5.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	6.44e-06	5.85e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	6.38e-06	5.8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	6.34e-06	5.76e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	6.32e-06	5.75e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	6.3e-06	5.73e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	6.28e-06	5.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	6.26e-06	5.69e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	6.22e-06	5.65e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—POMC—epilepsy syndrome	6.2e-06	5.63e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	6.2e-06	5.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	6.18e-06	5.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	6.17e-06	5.6e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	6.15e-06	5.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	6.12e-06	5.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	6.09e-06	5.53e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCL2—epilepsy syndrome	6.06e-06	5.51e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX1—epilepsy syndrome	6.01e-06	5.47e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—epilepsy syndrome	5.91e-06	5.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	5.86e-06	5.32e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	5.84e-06	5.31e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.8e-06	5.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.79e-06	5.26e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	5.78e-06	5.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	5.78e-06	5.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	5.77e-06	5.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	5.73e-06	5.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	5.71e-06	5.19e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	5.6e-06	5.09e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	5.58e-06	5.08e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	5.53e-06	5.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FGF2—epilepsy syndrome	5.48e-06	4.98e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	5.3e-06	4.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	5.28e-06	4.8e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AGT—epilepsy syndrome	5.27e-06	4.79e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	5.23e-06	4.75e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOE—epilepsy syndrome	5.17e-06	4.7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	5.15e-06	4.68e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	5.14e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	5.13e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	5.12e-06	4.66e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	5.12e-06	4.65e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	5.11e-06	4.64e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	5.09e-06	4.62e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RELA—epilepsy syndrome	5.09e-06	4.62e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	5.07e-06	4.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	5.06e-06	4.6e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MTOR—epilepsy syndrome	4.99e-06	4.53e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.95e-06	4.5e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.94e-06	4.49e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	4.9e-06	4.45e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.89e-06	4.44e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	4.88e-06	4.44e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	4.83e-06	4.39e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.76e-06	4.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	4.75e-06	4.32e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	4.7e-06	4.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.66e-06	4.24e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	4.65e-06	4.22e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	4.6e-06	4.18e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—epilepsy syndrome	4.59e-06	4.17e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—epilepsy syndrome	4.46e-06	4.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—POMC—epilepsy syndrome	4.44e-06	4.03e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	4.43e-06	4.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	4.42e-06	4.02e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	4.41e-06	4.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	4.41e-06	4.01e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	4.37e-06	3.97e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	4.37e-06	3.97e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—epilepsy syndrome	4.33e-06	3.94e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	4.33e-06	3.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	4.32e-06	3.93e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	4.28e-06	3.89e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	4.25e-06	3.86e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	4.23e-06	3.85e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—epilepsy syndrome	4.2e-06	3.82e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	4.19e-06	3.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.09e-06	3.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.07e-06	3.7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.07e-06	3.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.06e-06	3.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—epilepsy syndrome	4.05e-06	3.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.03e-06	3.67e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.02e-06	3.65e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—epilepsy syndrome	4e-06	3.63e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—epilepsy syndrome	3.89e-06	3.54e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	3.72e-06	3.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	3.71e-06	3.37e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.68e-06	3.34e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.64e-06	3.31e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.63e-06	3.3e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.6e-06	3.27e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.54e-06	3.22e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.29e-06	2.99e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.28e-06	2.98e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.25e-06	2.95e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.06e-06	2.78e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.05e-06	2.77e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.02e-06	2.74e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3e-06	2.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.99e-06	2.72e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—epilepsy syndrome	2.97e-06	2.7e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.96e-06	2.69e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.78e-06	2.53e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.77e-06	2.52e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.76e-06	2.51e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.75e-06	2.5e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.75e-06	2.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.72e-06	2.47e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.68e-06	2.43e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.67e-06	2.43e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.64e-06	2.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.61e-06	2.37e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.6e-06	2.36e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.57e-06	2.34e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.53e-06	2.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.52e-06	2.29e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.49e-06	2.27e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—epilepsy syndrome	2.48e-06	2.26e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.4e-06	2.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.39e-06	2.18e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.37e-06	2.15e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.34e-06	2.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.33e-06	2.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.31e-06	2.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.78e-06	1.62e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.49e-06	1.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.49e-06	1.35e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.47e-06	1.34e-05	CbGpPWpGaD
